Julie M. Sorg

Prognostic Impact of Atrial Rhythm and Dimension in Patients with Structural Heart Disease Undergoing Cardiac Sympathetic Denervation for Ventricular Arrhythmias.

J. Gornbein, K. Shivkumar, J. Bradfield, 2019, Heart rhythm.

Recurrent ventricular tachycardia after cardiac sympathetic denervation: Prolonged cycle length with improved hemodynamic tolerance and ablation outcomes

N. Boyle, K. Shivkumar, Duc H. Do, 2020, Journal of cardiovascular electrophysiology.

RENAL DENERVATION AS AN ADJUNCTIVE THERAPY TO CARDIAC SYMPATHETIC DENERVATION FOR ABLATION REFRACTORY VENTRICULAR TACHYCARDIA.

J. Moriarty, S. Kee, N. Boyle, 2020, Heart rhythm.

Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.

Marmar Vaseghi, Kalyanam Shivkumar, Rushil Shah, 2017, Journal of the American College of Cardiology.

Liver Disease as a Predictor of New‐Onset Atrial Fibrillation

M. Vaseghi, William A. Huang, Eric A. Dunipace, 2018, Journal of the American Heart Association.

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness

William T. Abraham, Todd M. Koelling, Leslie W. Miller, 2005 .

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation

J. Gornbein, N. Boyle, K. Shivkumar, 2021, Journal of the American Heart Association.